{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT02706951_SELECT_MONO\\NCT02706951_SELECT_MONO_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Full Analysis Set",
        "text": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug. The FAS will be used for all efficacy and baseline analyses.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug. The FAS will be used for all efficacy and baseline analyses.",
        "criteria": "Randomized AND received >= 1 dose of study drug"
      },
      {
        "id": "pop_2",
        "name": "Per Protocol Analysis Set",
        "text": "The Per Protocol Analysis Set represents a subset of the FAS and consists of all FAS subjects who did not meet any major protocol deviations during Period 1 of the study.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "populationDescription": "The Per Protocol Analysis Set represents a subset of the FAS and consists of all FAS subjects who did not meet any major protocol deviations during Period 1 of the study.",
        "criteria": "FAS AND no major protocol deviations during Period 1"
      },
      {
        "id": "pop_3",
        "name": "Safety Analysis Set",
        "text": "The Safety Analysis Set consists of all subjects who received at least one dose of study drug. For the Safety Analysis Set, subjects are assigned to a treatment group based on the 'as treated' treatment group, regardless of the treatment randomized.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "populationDescription": "The Safety Analysis Set consists of all subjects who received at least one dose of study drug. For the Safety Analysis Set, subjects are assigned to a treatment group based on the 'as treated' treatment group, regardless of the treatment randomized.",
        "criteria": "Received >= 1 dose of study drug"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "code": "AGE",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age at baseline in years"
      },
      {
        "id": "char_2",
        "name": "Tender Joint Count",
        "code": "TENDER_JOINT_COUNT",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Tender Joint Count",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Anatomical joints assessed for calculation of tender joint counts (TJC68)"
      },
      {
        "id": "char_3",
        "name": "Swollen Joint Count",
        "code": "SWOLLEN_JOINT_COUNT",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Swollen Joint Count",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Anatomical joints assessed for calculation of swollen joint counts (SJC66)"
      },
      {
        "id": "char_4",
        "name": "DAS28 (CRP)",
        "code": "DAS28_(CRP)",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "DAS28 (CRP)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Disease Activity Score 28 using C-reactive protein"
      }
    ],
    "summary": {
      "populationCount": 3,
      "characteristicCount": 4
    }
  }
}